Skip to search formSkip to main contentSkip to account menu

ipriflavone

Known as: 7-(1-methylethoxy)-3-phenyl-4H-1-benzopyran-4-one, 7-Isopropoxyisoflavone 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Objective. To investigate the therapeutic effects of ipriflavone on postmenopausal syndrome and osteoporosis in women. Methods. A… 
2005
2005
SummaryThe effect of ipriflavone (IP) on the proliferation and differentiation of rat osteoblast-like (ROB) cells and human… 
Review
1999
Review
1999
Ipriflavone, an isoflavone synthesized from the soy isoflavone daidzein, holds great promise in the prevention and treatment of… 
1995
1995
To assess the potential impact of ipriflavone on the biomechanical properties and mineral composition of bone, we administered… 
1994
1994
Ipriflavone (IP), an isoflavone derivative, has been shown to interfere with bone remodeling by inhibiting bone resorption and… 
1992
1992
Estrogen replacement therapy (ERT) has been demonstrated to prevent osteoporosis in postmenopausal women (PMW). However, several… 
1991
1991
Ipriflavone is a recently introduced anti-osteoporotic agent extensively metabolized to four major metabolites (M1, M2, M3, M5… 
1985
1985
Metabolic studies of ipriflavone (TC-80) in rats by gas-liquid chromatography-mass spectrometry led to the characterization of…